FAQ/Help |
Calendar |
Search |
Today's Posts |
04-24-2018, 03:23 PM | #1 | ||
|
|||
Member
|
Gocovri Improves Dyskinesia in Parkinson’s Patients Over Long Term, Phase 3 Trial Shows
Parkinson's Therapy Gocovri Improves Dyskinesia, Phase 3 Results Show |
||
Reply With Quote |
"Thanks for this!" says: | johnt (04-28-2018) |
|
|
Similar Threads | ||||
Thread | Forum | |||
Voyager’s Gene Therapy Improves Parkinson’s Patients’ Movement Over Long Term | Parkinson's Disease | |||
MRI-Focused Ultrasound Undergoing Phase 3 Clinical Trial for Parkinson’s Treatment | Parkinson's Disease | |||
Voyager’s Gene Therapy to Enter Phase 2/3 Trial Program for Adv Parkinson’s Dise | Parkinson's Disease | |||
Gocovri Approved by FDA as 1st Treatment for Levodopa-induced Dyskinesia in Parkinson | Parkinson's Disease | |||
Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's D | Parkinson's Disease |